Digital health PR that makes complex products understandable

Health technology can bring together engineers, clinicians, founders, patients and healthcare organisations. A journalist may need to understand what a service actually does, who it is intended for, what it has been tested to do and which claims remain unproven. A compelling press pitch is not simply a technology announcement containing the words innovation and healthcare.

Fair Public Relations helps suitable digital health companies, legitimate medical device businesses and qualified specialist sources develop credible earned-media opportunities. Our journalist-led boutique agency was founded by former UK national journalist Jordan Baker. We work from real product facts, appropriate evidence and the questions a publication's readers are trying to understand. We do not promise regulatory approval, treatment outcomes or guaranteed media coverage.

Digital Health & Medical Devices PR

PR for UK and US digital health and medical device businesses

We support suitable UK and US digital health companies, health technology founders and medical device businesses.

An American journalist may ask about how technology fits into healthcare delivery or which claims have been evaluated in the US; a British journalist may ask about implementation in a different care setting.

We distinguish the intended purpose, documented evidence and applicable permissions from marketing claims.

We never imply that approval or availability in one market establishes the same status in another.

Read more about our UK PR agency and US PR agency approaches

Understand the intended use before choosing a PR campaign

The phrase digital health describes businesses with very different roles. Some provide tools for healthcare professionals, some develop services used by patients and some supply technology to other organisations. A general wellbeing app may be a consumer product rather than a medical device.

Software or hardware designed for a medical purpose might require specific regulatory treatment in the markets where it is made available.

We establish what the product or service actually does and who is responsible for it before discussing an angle.

A business selling clinical equipment may need an editorial explanation for professional decision-makers, not a consumer buying guide.

A patient-facing platform may have a legitimate story about how its service is organised, provided we distinguish access and service design from clinical outcomes.

A founder can discuss the company, its development and actual operational experience, but clinical commentary must come from appropriately qualified sources.

An engineering lead may be the right spokesperson for a technical subject and a clinician for a medical one. In some businesses both are needed.

Technology PR is the adjacent sector for products whose principal story is general technology rather than healthcare; this page specifically addresses the evidence and professional responsibilities involved in health-related technology.

An evidence-led launch is not just a press release

Imagine a company introducing a digital tool designed for use within a defined healthcare workflow. The pitch needs a simple answer to several questions: what problem does the product address, who is the intended user, what does the tool actually do and what evidence supports the claim?

The fact that an application exists or uses an advanced model does not establish clinical benefit. An editor may want a clear demonstration, a reliable technical explanation and an appropriate source to answer medical questions. We would identify what can be shown safely and what must remain private.

For example, a demonstration might use synthetic information or approved test data rather than real patient records. A claimed reduction in process time might need a documented comparison and a clear explanation of the conditions under which the measurement was taken.

A claim about better clinical outcomes would require a different and appropriate evidence base. If the product is in development, undergoing evaluation or available only in a particular market, that status should be clear.

We would not announce an intended future feature as an existing capability.

A credible launch pitch may be narrower than the marketing team's initial description, but it gives the journalist something they can verify and explain accurately.

What healthcare, technology and business journalists need

A healthcare trade editor might be interested in how a legitimate product relates to a real professional workflow, whether its implementation has been documented and how the users are supported.

A technology reporter may want to understand the technical approach, limitations and distinction between a demonstration and a deployed feature.

A business publication might have a reason to cover a documented partnership, founder story, genuine investment announcement or expansion.

A consumer reporter may need a more accessible explanation of what the service does for its intended users.

These audiences do not need the same story. Funding, a pilot or a partnership may be a legitimate announcement if the facts and permissions are established, but none is evidence that a medical product works. We identify the reason the news matters and the person who can answer follow-up questions.

For a clinician's contribution, the profile must specify qualifications and actual scope.

For an engineering or founder interview, we make clear that their technical or commercial expertise is not a medical qualification.

We can develop more than one editorial strand through Standard PR where the business has suitable material, but a specialist individual seeking only commentary may be better served by focused Expert Commentary PR.

Distinguish product usability, technical performance and clinical evidence

A journalist reviewing a digital service may assess the way it presents information or the experience of using its public features. That is different from conducting a medical-device evaluation or testing the effectiveness of a treatment.

We do not ask a reporter to use an investigational or unsuitable product outside its appropriate conditions.

Any demonstration, sample or user account must be safe, properly authorised and accurately labelled. The company should provide the intended use, specifications, availability and limitations, along with a relevant evidence summary.

For clinical or technical claims, we need the original source and the relevant context. A study may have evaluated a measure of performance without establishing improved patient outcomes. A pilot in one setting may be useful evidence of implementation, but not proof that every healthcare organisation will obtain the same benefit. If the claim relates to a device's regulatory status, the exact market and wording must be verified by the client's appropriate specialist.

The FDA's device labelling guidance is one example of the need to pay attention to intended use and accurate description. Other jurisdictions and product categories have their own requirements.

We do not infer authorisation from the appearance of a product in an article, and are not a regulatory consultant.

Research, data, privacy and responsible health AI communication

A digital health business may have access to information about the people using its service. That information is often sensitive, and a communications opportunity does not override privacy responsibilities. Any proposed data-led story needs a clear account of what the information measures, how it was collected, which users were included, the period, geography and limitations.

Appropriate lawful permissions, safeguards and review must be in place. Removing obvious identifiers is not always sufficient to prevent identification, and we will not use real health records simply to make a demonstration more convincing.

Where a technology includes AI, we avoid describing model outputs as clinical judgement unless that claim is actually supported and appropriate. A demonstration in a limited test setting is not validation for every patient or use. The client needs to distinguish facts about a company's feature from claims about its safety, accuracy or benefit, and have the relevant technical and clinical people review them. We also consider commercial interests and dependencies.

An article should not present a health tool as a substitute for an appropriate professional assessment.

We only pursue angles that are legitimate and within the client's actual permissions, even if a more ambitious claim would attract more attention.

Evidence from healthcare services and wellbeing technology

Our historical Swift Doctor case study illustrates PR for an online pharmacy and healthcare service. Its documented wider archive consists of 45 distinct linked press records, with dates spanning a longer period than the stated engagement. We keep the two measures separate. The service's qualified doctors and pharmacists provided relevant explanations for journalists covering health topics.

The example demonstrates how a digital healthcare business can contribute to editorial reporting through properly attributed professional expertise. It is not a medical-device launch campaign or evidence of a product's clinical performance.

Our moonbird case study documents 25 published articles across 20 publication titles in six months, involving product and expert-led opportunities for a breathing and wellbeing product. That adjacent example shows the possible combination of independent product assessment and suitable founder or expert information, not validation of a regulated medical-device claim.

We distinguish the evidence from these campaigns from the evidence a new health technology company needs for its own products, clinical team and intended use. The most relevant digital health story is one the client's actual documentation and expertise can support.

Support professional, partner and customer discovery

A decision-maker researching a health technology supplier is likely to evaluate the product's functionality, evidence, regulatory status, support and suitability for their setting. An independent article can provide useful context about the company's development or the knowledge behind a service.

The business might reference an accurate trade interview in an introduction to a potential partner, or link a relevant founder profile from its website. Such coverage is not clinical due diligence, independent technical certification or a recommendation to purchase.

We assess the relevance of published pieces, links and accurate citations separately from actual enquiries, demonstrations, procurement conversations or sales. Press coverage can help people discover information about the business, including through search and AI-assisted tools, but no placement guarantees rankings, AI recommendations or contracts. Commercial outcomes depend in part on the client's actual product, evidence, professional support, market access and sales process.

The aim is to make a legitimate health technology proposition understandable and discoverable without manufacturing medical authority or suggesting early-stage research has established a clinical result.

Read the Swift Doctor case study

How much does Digital Health & Medical Devices PR cost?

Standard PR supports wider business PR, including relevant expert commentary, founder stories, services or products and genuine announcements where appropriate. The monthly fee is £797 in the UK, US$997 in the US and CAD$1,497 in Canada. The initial commitment is three months, followed by one full billing cycle's notice.

Eligible individual experts who only need focused commentary outreach may consider the separate Expert Commentary PR service, currently £397 in the UK, US$497 in the US or CAD$747 in Canada per month. It is not a cheaper substitute for a wider company, service or product campaign.

UK clients are serviced by our London team and US clients by our New York team; we also support suitable Canadian clients.

Further reading and related services

  • How technology companies get media coverage without funding announcements

    How technology companies get media coverage without funding announcements

  • Healthcare PR: research and patient stories

    Healthcare PR: research and patient stories

  • Doctor media profile checklist

    Doctor media profile checklist

Still Have Questions? We’ve Got You

Want more detail?

You can read our full FAQs for more information on how we work, reporting, approvals, AI, media contacts and what to expect from earned coverage.

Discuss your campaign with Fair PR

Tell us about your real expertise, practice or business, market and goals.

We will assess the genuine editorial opportunities and which existing service fits.

We do not buy placements or guarantee coverage, clinical outcomes or appointments.